FDA’s New Priority Voucher Pilot Program Has Landed: CNPV
FDA Law
JUNE 18, 2025
As defined by the National Cancer Institute, tumor board meetings convene multidisciplinary specialists to decide on the best treatment plan for new and complex cancer cases. FDA plans to issue a limited number of vouchers, without specifying an exact number as of yet. The vouchers will be issued to “companies aligned with U.S.
59 
Let's personalize your content